glutathione inhalation therapy for silicosis Advances in Inhaled Nanoparticle Drug Delivery Pulmonary Disease Management International Journal of Molecular Medicine
International Journal of Molecular Medicine Frontiers Hydrogen improves the efficacy of tetrandrine in the treatment of silicosis by inhibiting vascular endothelial mesenchymal transition caused by oxidative stress The Treatment of Pulmonary Diseases and Respiratory Related Conditions with Inhaled (Nebulized or Aerosolized) Glutathione PMC glutathione inhalation therapy for silicosis Efficient pulmonary targeted and mechanistic insights of a novel dry powder inhaler in a model of radiation induced lung injury Ferroptosis and iron metabolism drive Natural Products Based Inhaled Formulations for Treating Pulmonary Diseases PMC
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




